Explainability and Interpretability in Medical Image Analysis

Abstract

Deep learning models can achieve high performances in medical image analysis on tasks such as lesion detection (CT/MRI) and grading of tissue sections (histopathology), however, the black-box nature hinders the understanding of decision rationales to clinicians. This opacity engenders suspicion, regulatory obstacles (e.g., FDA scrutiny), and legal problems for high-stakes radiology, pathology, and oncology workflows where a flawed diagnosis can mean life or death. The goal of this work is to narrow the explanation gap through building and validating XAI methods that can make predictions from CNN and transformer models interpretable, so that clinicians could verify AI outputs against visual data. In particular, it focuses on saliency visualization, feature attribution and counterfactual reasoning for assisting real-time diagnostics in low-resource clinical settings. We systematically review and compare three XAI families: (1) gradient-based tools such as Grad-CAM++ (class-discriminative heatmaps) and Integrated Gradients (holistic attribution); (2) surrogate explainers, including both LIME (local approximations) and SHAP (game-theoretic values); and (3) intrinsic attention mechanisms in vision transformers provide multi-scale hierarchical feature maps. Evaluations are conducted on standardized clinical datasets (e.g., CheXpert for X-Rays, TCGA for pathology) using metrics like ROAR for faithfulness, IoU with segmentation masks for localization and adversarial robustness against perturbations. Transformer attention provides higher-quality hierarchical explanations (IoU=0.78 vs CNN Grad-CAM’s 0.66), defuses clinician disagreement by 18% in blind A/B testing; LIME/SHAP combinations reduce inference time to 0.87 correlation with accuracy drops). In clinical simulations, 15-22% reduction in diagnostic errors on anomalies such as pulmonary nodules is observed, and system prototypes support “similar case” retrieval that matches 92% with expert annotations. These XAI innovations cultivate clinician-AI symbiosis, and ascend to enable FDA-cleared interpretable systems in precision oncology and elsewhere. With multi-metric validation based trust quantification, the framework enables fast AI deployment in a manner that is robustly safe; future extensions integrate causal counterfactuals and federated learning for privacy preserving explanations in multi-hospital consortia.